21 February 2025 : Clinical Research
Long-Term Outcomes of Implanon in Managing Adenomyosis: A 3-Year Prospective Study
Na Jiao ABCDEF 1, Jie Wang AB 1,2, Hongxin Mu AB 1,2, Qiwei Qi ABCDEFG 1,2*DOI: 10.12659/MSM.945972
Med Sci Monit 2025; 31:e945972
Table 1 Demographic characteristics, menstrual and fertility history of subjects.
| Characteristic | Overall, N=124 (100.00) | Adenomyosis | P value | |
|---|---|---|---|---|
| Without, N=79 (63.71) | With, N=45 (36.29) | |||
| 36.53±6.10 | 34.04±5.03 | 40.91±5.34 | ||
| <35 years | 54 (43.55) | 45 (56.96) | 9 (20.00) | |
| ≥35 years | 70 (56.45) | 34 (43.04) | 36 (80.00) | |
| 0.457 | ||||
| Underweight (<18.5) | 7 (5.65) | 6 (7.59) | 1 (2.22) | |
| Normal (18.5 to <24) | 85 (68.55) | 53 (67.09) | 32 (71.11) | |
| Overweight (24 to <28) | 26 (20.97) | 15 (18.99) | 11 (24.44) | |
| Obese (28 or greater) | 6 (4.84) | 5 (6.33) | 1 (2.22) | |
| 0.623 | ||||
| Underweight (<18.5) | 7 (5.65) | 6 (7.59) | 1 (2.22) | |
| Normal (18.5 to <24) | 76 (61.29) | 47 (59.49) | 29 (64.44) | |
| Overweight (24 to <28) | 33 (26.61) | 20 (25.32) | 13 (28.89) | |
| Obese (28 or greater) | 8 (6.45) | 6 (7.59) | 2 (4.44) | |
| 0.296 | ||||
| Abnormal (<21 or >45 days) | 4 (3.23) | 4 (5.06) | 0 (0.00) | |
| Normal (21–45 days) | 120 (96.77) | 75 (94.94) | 45 (100.00) | |
| 0.363 | ||||
| Abnormal (<3 or >7 days) | 1 (0.81) | 0 (0.00) | 1 (2.22) | |
| Normal (3–7 days) | 123 (99.19) | 79 (100.00) | 44 (97.78) | |
| 0.086 | ||||
| 0 | 4 (3.23) | 3 (3.80) | 1 (2.22) | |
| 1 | 17 (13.71) | 7 (8.86) | 10 (22.22) | |
| 2 | 30 (24.19) | 16 (20.25) | 14 (31.11) | |
| 3 | 40 (32.26) | 28 (35.44) | 12 (26.67) | |
| ≥4 | 33 (26.61) | 25 (31.65) | 8 (17.78) | |
| 0 | 5 (4.03) | 4 (5.06) | 1 (2.22) | |
| 1 | 84 (67.74) | 47 (59.49) | 37 (82.22) | |
| ≥2 | 35 (28.23) | 28 (35.44) | 7 (15.56) | |
| 0.338 | ||||
| 0 | 28 (22.58) | 15 (18.99) | 13 (28.89) | |
| 1 | 35 (28.23) | 22 (27.85) | 13 (28.89) | |
| 2 | 38 (30.65) | 24 (30.38) | 14 (31.11) | |
| ≥3 | 23 (18.55) | 18 (22.78) | 5 (11.11) | |